JP2024133479A5 - - Google Patents

Download PDF

Info

Publication number
JP2024133479A5
JP2024133479A5 JP2024091954A JP2024091954A JP2024133479A5 JP 2024133479 A5 JP2024133479 A5 JP 2024133479A5 JP 2024091954 A JP2024091954 A JP 2024091954A JP 2024091954 A JP2024091954 A JP 2024091954A JP 2024133479 A5 JP2024133479 A5 JP 2024133479A5
Authority
JP
Japan
Prior art keywords
composition
use according
subject
brain
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024091954A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024133479A (ja
JP7807105B2 (ja
Filing date
Publication date
Priority claimed from JP2021511593A external-priority patent/JP7587275B2/ja
Application filed filed Critical
Publication of JP2024133479A publication Critical patent/JP2024133479A/ja
Publication of JP2024133479A5 publication Critical patent/JP2024133479A5/ja
Priority to JP2026000974A priority Critical patent/JP2026082833A/ja
Application granted granted Critical
Publication of JP7807105B2 publication Critical patent/JP7807105B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024091954A 2018-08-30 2024-06-06 筋萎縮性側索硬化症の治療方法または予防方法 Active JP7807105B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026000974A JP2026082833A (ja) 2018-08-30 2026-01-06 筋萎縮性側索硬化症の治療方法または予防方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862724780P 2018-08-30 2018-08-30
US62/724,780 2018-08-30
JP2021511593A JP7587275B2 (ja) 2018-08-30 2019-08-30 筋萎縮性側索硬化症の治療方法または予防方法
PCT/US2019/048985 WO2020047368A1 (en) 2018-08-30 2019-08-30 Methods of treating or preventing amyotrophic lateral sclerosis

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021511593A Division JP7587275B2 (ja) 2018-08-30 2019-08-30 筋萎縮性側索硬化症の治療方法または予防方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026000974A Division JP2026082833A (ja) 2018-08-30 2026-01-06 筋萎縮性側索硬化症の治療方法または予防方法

Publications (3)

Publication Number Publication Date
JP2024133479A JP2024133479A (ja) 2024-10-02
JP2024133479A5 true JP2024133479A5 (cg-RX-API-DMAC7.html) 2024-11-14
JP7807105B2 JP7807105B2 (ja) 2026-01-27

Family

ID=69643060

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021511593A Active JP7587275B2 (ja) 2018-08-30 2019-08-30 筋萎縮性側索硬化症の治療方法または予防方法
JP2024091954A Active JP7807105B2 (ja) 2018-08-30 2024-06-06 筋萎縮性側索硬化症の治療方法または予防方法
JP2026000974A Pending JP2026082833A (ja) 2018-08-30 2026-01-06 筋萎縮性側索硬化症の治療方法または予防方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021511593A Active JP7587275B2 (ja) 2018-08-30 2019-08-30 筋萎縮性側索硬化症の治療方法または予防方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026000974A Pending JP2026082833A (ja) 2018-08-30 2026-01-06 筋萎縮性側索硬化症の治療方法または予防方法

Country Status (9)

Country Link
US (2) US12508327B2 (cg-RX-API-DMAC7.html)
EP (1) EP3844285A4 (cg-RX-API-DMAC7.html)
JP (3) JP7587275B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210053305A (cg-RX-API-DMAC7.html)
CN (1) CN112673107A (cg-RX-API-DMAC7.html)
AU (2) AU2019328337B2 (cg-RX-API-DMAC7.html)
CA (1) CA3107612A1 (cg-RX-API-DMAC7.html)
IL (1) IL280965B2 (cg-RX-API-DMAC7.html)
WO (1) WO2020047368A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7587275B2 (ja) * 2018-08-30 2024-11-20 ローワン・ユニバーシティ 筋萎縮性側索硬化症の治療方法または予防方法
WO2025240562A1 (en) * 2024-05-15 2025-11-20 Woolsey Pharmaceuticals, Inc. Method of treating amyotrophic lateral sclerosis with trimetazidine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753379B1 (fr) 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa Methode de traitement de la sclerose laterale amyotrophique
FR2923962B1 (fr) * 2007-11-20 2009-11-20 Valeo Sys Controle Moteur Sas Circuit elevateur de tension
DK2561073T3 (en) * 2010-04-23 2016-12-12 Univ Massachusetts Aav vectors targeted to central nervous system and methods of use thereof
EP2861733B1 (en) * 2012-05-30 2020-10-07 Rowan University Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of n-acetyl-aspartic acid
US11413356B2 (en) * 2016-04-15 2022-08-16 University Of Massachusetts Methods and compositions for treating metabolic imbalance
JP7587275B2 (ja) 2018-08-30 2024-11-20 ローワン・ユニバーシティ 筋萎縮性側索硬化症の治療方法または予防方法

Similar Documents

Publication Publication Date Title
JP2024020346A (ja) 筋疾患の治療のための改変aavカプシドポリペプチド
JP2019089787A5 (cg-RX-API-DMAC7.html)
JP6832280B2 (ja) 新規のマイクロジストロフィンおよび使用の関連する方法
JP2020518259A5 (cg-RX-API-DMAC7.html)
US12146150B2 (en) Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery
JP2024513949A5 (cg-RX-API-DMAC7.html)
US20250057899A1 (en) Gene therapy for ciliopathies
TW201629225A (zh) 第九因子基因療法
JP2023534037A5 (cg-RX-API-DMAC7.html)
RU2019103488A (ru) Способы и композиции для лечения нарушений и заболеваний, связанных с rdh12
JP2022551739A5 (cg-RX-API-DMAC7.html)
JP2020172505A5 (cg-RX-API-DMAC7.html)
JP2019524090A5 (cg-RX-API-DMAC7.html)
JP2021533126A (ja) 臓器機能を制御するための遺伝子治療方法
JP2023126658A5 (cg-RX-API-DMAC7.html)
JP2024545186A5 (cg-RX-API-DMAC7.html)
JP2022513454A (ja) AIMP2-DX2およびmiR-142の標的核酸を含むベクター、ならびにその使用
JP2021533801A5 (cg-RX-API-DMAC7.html)
JP2021535168A5 (cg-RX-API-DMAC7.html)
JP2022519597A5 (cg-RX-API-DMAC7.html)
US10639351B2 (en) Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factor
JP2021523093A (ja) 優性遺伝性カテコラミン誘発多形性心室頻拍の治療のための組成物および方法
JP2023536067A5 (cg-RX-API-DMAC7.html)
WO2022187671A1 (en) Compositions and methods for the treatment of hemophilia
JP2022514271A5 (cg-RX-API-DMAC7.html)